Complications of Intrathecal Therapy
暂无分享,去创建一个
[1] P. Staats,et al. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. , 2008, Pain medicine.
[2] S. Hassenbusch,et al. Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.
[3] T. Yaksh,et al. Time Course and Role of Morphine Dose and Concentration in Intrathecal Granuloma Formation in Dogs: A Combined Magnetic Resonance Imaging and Histopathology Investigation , 2006, Anesthesiology.
[4] T. Yaksh,et al. Opiate Pharmacology of Intrathecal Granulomas , 2006, Anesthesiology.
[5] M. Byas-Smith,et al. Intrathecal Ziconotide in the Treatment of Chronic Nonmalignant Pain: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial , 2006, Neuromodulation : journal of the International Neuromodulation Society.
[6] M. Cousins,et al. Intrathecal catheter granuloma associated with isolated baclofen infusion. , 2006, Anesthesia and analgesia.
[7] S. Hassenbusch,et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. , 2004, Journal of pain and symptom management.
[8] M. Byas-Smith,et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. , 2004, JAMA.
[9] K. Follett. Intrathecal analgesia and catheter-tip inflammatory masses. , 2003, Anesthesiology.
[10] C. Sommer,et al. Chronically Infused Intrathecal Morphine in Dogs , 2003, Anesthesiology.
[11] Marion R McMillan,et al. Catheter-associated masses in patients receiving intrathecal analgesic therapy. , 2003 .
[12] Thomas J. Smith,et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] L. J. Roberts,et al. Sex Hormone Suppression by Intrathecal Opioids: A Prospective Study , 2002, The Clinical journal of pain.
[14] R. Coffey,et al. Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.
[15] L. J. Roberts,et al. Hypogonadism in patients treated with intrathecal morphine. , 2000, The Clinical journal of pain.
[16] O. Sagher,et al. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. , 1998, Neurosurgery.
[17] E. Krames,et al. Clinical realities and economic considerations: patient selection in intrathecal therapy. , 1997, Journal of pain and symptom management.
[18] D. Long,et al. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. , 1991, Neurosurgery.
[19] A. Pinchak,et al. LOW-COST MICROCOMPUTER GENERATION OF PHYSIOLOGIC PROFILE , 1979 .
[20] John E. Thomas,et al. Pain relief by intrathecally applied morphine in man. , 1979, Anesthesiology.